Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.20)
# 1,202
Out of 4,502 analysts
391
Total ratings
33.87%
Success rate
5.4%
Average return
Main Sectors:
44 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYXI Zynex | Maintains: Buy | $21 → $16 | $10.19 | +57.02% | 13 | Jul 26, 2024 | |
| ANIX Anixa Biosciences | Reiterates: Buy | $7 | $2.89 | +142.21% | 15 | Jul 24, 2024 | |
| KPRX Kiora Pharmaceuticals | Maintains: Buy | $2 → $10 | $4.69 | +113.22% | 13 | Jul 23, 2024 | |
| LEXX Lexaria Bioscience | Reiterates: Buy | $10 | $3.09 | +223.62% | 2 | Jul 18, 2024 | |
| ANGO AngioDynamics | Reiterates: Buy | $14 | $7.51 | +86.42% | 5 | Jul 17, 2024 | |
| RNLX Renalytix | Reiterates: Buy | $3 | $0.30 | +884.57% | 9 | Jul 12, 2024 | |
| OKYO OKYO Pharma | Reiterates: Buy | $7 | $1.35 | +418.52% | 6 | Jul 12, 2024 | |
| ICCM IceCure Medical | Reiterates: Buy | $3 | $0.80 | +275.05% | 15 | Jul 2, 2024 | |
| EYPT EyePoint Pharmaceuticals | Reiterates: Buy | $30 | $9.46 | +217.12% | 17 | Jun 27, 2024 | |
| DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $2.11 | +326.54% | 12 | Jun 26, 2024 | |
| ALIM Alimera Sciences | Downgrades: Neutral | $6 | $5.59 | +7.33% | 15 | Jun 25, 2024 | |
| RGNX REGENXBIO | Reiterates: Buy | $38 | $14.39 | +164.07% | 3 | Jun 20, 2024 | |
| CODX Co-Diagnostics | Reiterates: Neutral | $2 | $1.10 | +81.82% | 14 | Jun 17, 2024 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $14 | $8.28 | +69.08% | 17 | Jun 14, 2024 | |
| BLTE Belite Bio | Reiterates: Buy | $59 | $48.35 | +22.03% | 14 | Jun 13, 2024 | |
| OCS Oculis Holding AG | Maintains: Buy | $28 → $30 | $11.45 | +162.01% | 8 | Jun 11, 2024 | |
| APDN Applied DNA Sciences | Maintains: Buy | $7 → $1.5 | $0.43 | +252.94% | 18 | Jun 10, 2024 | |
| BRNS Barinthus Biotherapeutics | Reiterates: Buy | $8 | $1.46 | +447.95% | 6 | Jun 7, 2024 | |
| CDNA CareDx | Reiterates: Neutral | n/a | $18.87 | - | 4 | May 31, 2024 | |
| GLSI Greenwich LifeSciences | Reiterates: Buy | $36 | $16.62 | +116.61% | 5 | May 22, 2024 | |
| KALA Kala Pharmaceuticals | Maintains: Buy | $21 → $18 | $7.24 | +148.62% | 16 | May 17, 2024 | |
| GNPX Genprex | Reiterates: Buy | $10 | $1.93 | +418.13% | 5 | May 17, 2024 | |
| TRML Tourmaline Bio | Reiterates: Buy | $48 | $17.12 | +180.37% | 2 | May 14, 2024 | |
| SRTS Sensus Healthcare | Maintains: Buy | $8 → $10 | $6.34 | +57.73% | 12 | May 13, 2024 | |
| CLSD Clearside Biomedical | Maintains: Buy | $6 → $5 | $1.13 | +342.48% | 14 | May 13, 2024 | |
| VERU Veru Inc. | Reiterates: Buy | $3 | $0.95 | +216.46% | 16 | May 13, 2024 | |
| LFMD LifeMD | Reiterates: Buy | $12 | $6.96 | +72.41% | 6 | May 10, 2024 | |
| OPK OPKO Health | Reiterates: Buy | $3 | $1.42 | +111.27% | 7 | May 8, 2024 | |
| ASLN ASLAN Pharmaceuticals | Reiterates: Buy | $72 | $0.60 | +11,900.00% | 19 | May 3, 2024 | |
| BLCO Bausch + Lomb | Reiterates: Buy | $20 | $15.53 | +28.78% | 11 | May 2, 2024 | |
| MYNZ Mainz Biomed B.V. | Maintains: Buy | $5 → $3 | $0.35 | +747.46% | 9 | Mar 6, 2024 | |
| PRPH ProPhase Labs | Reiterates: Buy | $11 | $3.03 | +263.04% | 14 | Feb 21, 2024 | |
| MOTS Motus GI Holdings | Reiterates: Buy | $38 | $0.07 | +55,870.15% | 9 | Sep 27, 2023 | |
| NMRD Nemaura Medical | Maintains: Buy | $7 → $2.5 | $0.11 | +2,274.17% | 4 | Aug 21, 2023 | |
| OPGN OpGen | Downgrades: Neutral | n/a | $3.06 | - | 6 | Aug 14, 2023 | |
| CNTG Centogene | Reiterates: Buy | $1.5 | $0.35 | +334.03% | 8 | Jun 28, 2023 | |
| CHEK Check-Cap | Downgrades: Neutral | n/a | $2.02 | - | 5 | Jun 7, 2023 | |
| BPTH Bio-Path Holdings | Maintains: Buy | $240 → $180 | $1.77 | +10,044.85% | 1 | May 19, 2022 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $58 → $48 | $26.43 | +81.61% | 5 | Apr 22, 2022 | |
| IDXG Interpace Biosciences | Downgrades: Neutral | n/a | $1.15 | - | 4 | Nov 17, 2021 | |
| EYEN Eyenovia | Maintains: Buy | n/a | $1.44 | - | 2 | Apr 1, 2021 | |
| CELC Celcuity | Maintains: Buy | n/a | $19.15 | - | 2 | Feb 17, 2021 | |
| CYDY CytoDyn | Reiterates: Buy | n/a | $0.14 | - | 2 | Apr 28, 2020 | |
| OGEN Oragenics | Downgrades: Neutral | n/a | $1.01 | - | 1 | Apr 16, 2020 |
Zynex
Jul 26, 2024
Maintains: Buy
Price Target: $21 → $16
Current: $10.19
Upside: +57.02%
Anixa Biosciences
Jul 24, 2024
Reiterates: Buy
Price Target: $7
Current: $2.89
Upside: +142.21%
Kiora Pharmaceuticals
Jul 23, 2024
Maintains: Buy
Price Target: $2 → $10
Current: $4.69
Upside: +113.22%
Lexaria Bioscience
Jul 18, 2024
Reiterates: Buy
Price Target: $10
Current: $3.09
Upside: +223.62%
AngioDynamics
Jul 17, 2024
Reiterates: Buy
Price Target: $14
Current: $7.51
Upside: +86.42%
Renalytix
Jul 12, 2024
Reiterates: Buy
Price Target: $3
Current: $0.30
Upside: +884.57%
OKYO Pharma
Jul 12, 2024
Reiterates: Buy
Price Target: $7
Current: $1.35
Upside: +418.52%
IceCure Medical
Jul 2, 2024
Reiterates: Buy
Price Target: $3
Current: $0.80
Upside: +275.05%
EyePoint Pharmaceuticals
Jun 27, 2024
Reiterates: Buy
Price Target: $30
Current: $9.46
Upside: +217.12%
Alpha Tau Medical
Jun 26, 2024
Reiterates: Buy
Price Target: $9
Current: $2.11
Upside: +326.54%
Alimera Sciences
Jun 25, 2024
Downgrades: Neutral
Price Target: $6
Current: $5.59
Upside: +7.33%
REGENXBIO
Jun 20, 2024
Reiterates: Buy
Price Target: $38
Current: $14.39
Upside: +164.07%
Co-Diagnostics
Jun 17, 2024
Reiterates: Neutral
Price Target: $2
Current: $1.10
Upside: +81.82%
Ocular Therapeutix
Jun 14, 2024
Reiterates: Buy
Price Target: $14
Current: $8.28
Upside: +69.08%
Belite Bio
Jun 13, 2024
Reiterates: Buy
Price Target: $59
Current: $48.35
Upside: +22.03%
Oculis Holding AG
Jun 11, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $11.45
Upside: +162.01%
Applied DNA Sciences
Jun 10, 2024
Maintains: Buy
Price Target: $7 → $1.5
Current: $0.43
Upside: +252.94%
Barinthus Biotherapeutics
Jun 7, 2024
Reiterates: Buy
Price Target: $8
Current: $1.46
Upside: +447.95%
CareDx
May 31, 2024
Reiterates: Neutral
Price Target: n/a
Current: $18.87
Upside: -
Greenwich LifeSciences
May 22, 2024
Reiterates: Buy
Price Target: $36
Current: $16.62
Upside: +116.61%
Kala Pharmaceuticals
May 17, 2024
Maintains: Buy
Price Target: $21 → $18
Current: $7.24
Upside: +148.62%
Genprex
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $1.93
Upside: +418.13%
Tourmaline Bio
May 14, 2024
Reiterates: Buy
Price Target: $48
Current: $17.12
Upside: +180.37%
Sensus Healthcare
May 13, 2024
Maintains: Buy
Price Target: $8 → $10
Current: $6.34
Upside: +57.73%
Clearside Biomedical
May 13, 2024
Maintains: Buy
Price Target: $6 → $5
Current: $1.13
Upside: +342.48%
Veru Inc.
May 13, 2024
Reiterates: Buy
Price Target: $3
Current: $0.95
Upside: +216.46%
LifeMD
May 10, 2024
Reiterates: Buy
Price Target: $12
Current: $6.96
Upside: +72.41%
OPKO Health
May 8, 2024
Reiterates: Buy
Price Target: $3
Current: $1.42
Upside: +111.27%
ASLAN Pharmaceuticals
May 3, 2024
Reiterates: Buy
Price Target: $72
Current: $0.60
Upside: +11,900.00%
Bausch + Lomb
May 2, 2024
Reiterates: Buy
Price Target: $20
Current: $15.53
Upside: +28.78%
Mainz Biomed B.V.
Mar 6, 2024
Maintains: Buy
Price Target: $5 → $3
Current: $0.35
Upside: +747.46%
ProPhase Labs
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $3.03
Upside: +263.04%
Motus GI Holdings
Sep 27, 2023
Reiterates: Buy
Price Target: $38
Current: $0.07
Upside: +55,870.15%
Nemaura Medical
Aug 21, 2023
Maintains: Buy
Price Target: $7 → $2.5
Current: $0.11
Upside: +2,274.17%
OpGen
Aug 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.06
Upside: -
Centogene
Jun 28, 2023
Reiterates: Buy
Price Target: $1.5
Current: $0.35
Upside: +334.03%
Check-Cap
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.02
Upside: -
Bio-Path Holdings
May 19, 2022
Maintains: Buy
Price Target: $240 → $180
Current: $1.77
Upside: +10,044.85%
DENTSPLY SIRONA
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $26.43
Upside: +81.61%
Interpace Biosciences
Nov 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.15
Upside: -
Eyenovia
Apr 1, 2021
Maintains: Buy
Price Target: n/a
Current: $1.44
Upside: -
Celcuity
Feb 17, 2021
Maintains: Buy
Price Target: n/a
Current: $19.15
Upside: -
CytoDyn
Apr 28, 2020
Reiterates: Buy
Price Target: n/a
Current: $0.14
Upside: -
Oragenics
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.01
Upside: -